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Conclusions: The information sessions, using the PEARL 
software, were popular with our patients. This pilot study has 
served to help plan a further study wherein the session will 
be staged, post CT planning, but prior to treatment. In turn 
this will act as a pilot to produce evidence to support an 
intended randomised study to test the hypothesis that 
appropriate information given via this graphical interface will 
promote greater compliance with prostate patients and result 
in fewer 'on treatment' interventions. 
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Purpose/Objective: Use of three-dimensional (3D) virtual 
reality (VR) technology in patient information is a novel tool 
in radiotherapy (RT). Results from a pilot project on using 3D 
VR technology in the information to patients and relatives 
showed that all participants (n=89) in six ‘Open house’ 
sessions reported that VR was useful in the understanding of 
RT. A total of 97% replied they had found answers to 
questions they had been contemplating during the course of 
their treatment. Several patients expressed a wish to get 
their own treatment plan presented in 3D. The aim of this 
study was to test if showing patients their own RT dose plan 
in 3D would increase their knowledge of and confidence in RT 
treatment.  
Materials and Methods: All patients (n=58) with cancer in the 
pelvic area starting curative RT during a period of 2½ months 
were offered a presentation of their own dose plan using 3D 
VR technology (VERTUAL Ltd.). Relatives were invited to 
participate. Oral and written information about RT 
supplemented with information on DVD, had been given 
previously. Before the 3D presentation, participants filled in 
a questionnaire including questions about confidence and 
knowledge about the target of RT, CT-scans and dose 
planning, positioning and dose delivery, possible side effects 
and causes of side effects. After the VR presentation the 
participants evaluated the same topics again with focus on 
level of confidence, amount of new knowledge and 
importance of the new knowledge; it was possible to 
supplement with comments. The patient filled in the 
questionnaire in collaboration with the project manager. 
Results: Response was obtained from 32 of 58 included 
patients (58%); Average age was 64 years (38-79). Number of 
completed fractions at time of VR session was 9 on average 
(range 3-36). Relatives participated in almost half of the 
presentation sessions (n=15). A total of 41% of the 
participants reported a higher level of confidence in the RT 
treatment after the presentation; none reported a lower 
level. Figure 1 shows amount of new knowledge and the 
importance of the new knowledge according to patients. Both 
patients and relatives evaluated the presentations as 
informative and relevant; statements included: 'It’s 
important to see my own dose plan, this clarifies organs 
being radiated and how healthy tissue can be spared', and 
'I’ve got a better understanding of what’s going on with my 
husband'. 
 
Conclusions: It seems that presentation of patients own dose 
plan in 3D VR gives a visual understanding for most patients. 
A high number of patients reported they received important 
new knowledge about target definition, planning of 
treatment, positioning, possible side effects and causes of 
side effects.  
The presentations also lead to increased confidence about 
RT. The 3D VR technique makes it easier for patients and 
relatives to understand a high-technology treatment and can 
be used as supplement to inform about RT. 
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Purpose/Objective: The Department of Health (DH) state 
that access to appropriate and timely radiotherapy (RT) 
services, including modern techniques such as Intensity-
Modulated Radiotherapy (IMRT) and Image-Guided 
Radiotherapy (IGRT), is crucial in improving outcomes for 
cancer patients. It has been estimated that current UK 
services will be inadequate to treat future populations in a 
timely and effective manner, and that more investment is 
needed for RT provision. The National Radiotherapy Advisory 
Group (NRAG) recommended commissioning of more fractions 
to combat increasing demand in an ageing UK population. 
Commissioners recognise that workload and factors affecting 
efficiency need to be addressed, however few studies 
consider the daily demand of a linear accelerator. There is a 
lack of ‘real-time’ data regarding the impact of increasingly 
complex techniques on treatment times and whether current 
scheduling is reflective of time needed for RT delivery. 
Materials and Methods: A systematic quantitative process 
evaluation was undertaken in a large regional cancer centre, 
including a satellite centre, between January and April 2014. 
